Status
ACTIVE
Global HQ
Cambridge, England
Countries of investment
- United Kingdom
Investment stages
- Seed
Industries
- AI
- Health Tech
About
Mogrify is a pioneering biotechnology company located in Cambridge, UK, dedicated to revolutionizing the treatment of degenerative diseases through innovative in vivo reprogramming therapies. By harnessing its proprietary platform technologies, Mogrify identifies critical cellular switches that enable the transformation of one cell type into another, facilitating targeted and effective regeneration of damaged tissues. The company's commitment to advancing regenerative medicine underscores its mission to improve patient outcomes and enhance quality of life for those affected by debilitating conditions. Through rigorous research and development, Mogrify seeks to establish itself as a leader in the biotechnology field, providing groundbreaking solutions that address unmet medical needs.
Mogrify is a pioneering biotechnology company located in Cambridge, UK, dedicated to revolutionizing the treatment of degenerative diseases through innovative in vivo reprogramming therapies. By harnessing its proprietary platform technologies, Mogrify identifies critical cellular switches that enable the transformation of one cell type into another, facilitating targeted and effective regeneration of damaged tissues. The company's commitment to advancing regenerative medicine underscores its mission to improve patient outcomes and enhance quality of life for those affected by debilitating conditions. Through rigorous research and development, Mogrify seeks to establish itself as a leader in the biotechnology field, providing groundbreaking solutions that address unmet medical needs.
Investment Thesis
Mogrify invests in biotechnology startups, particularly those focusing on innovative approaches to cell and gene therapy, aiming for transformative healthcare solutions.